← Browse by Condition
Medical Condition
t cell acute lymphoblastic leukemia
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 1
NCT05679895 Phase 1
Recruiting
Safety and Efficacy of OC-1 Therapy in Patients With R/R T-ALL/LL
Enrollment
20 pts
Location
Spain
Sponsor
OneChain Immunotherapeutics
NCT03081910 Phase 1
Recruiting
Autologous T-Cells Expressing a Second Generation CAR for Treatment of T-Cell Malignancies Expressing CD5 Antigen
Enrollment
54 pts
Location
United States
Sponsor
Baylor College of Medicine
NCT05995028 Phase 1
Recruiting
Universal 4SCAR7U Targeting CD7-positive Malignancies
Enrollment
30 pts
Location
China
Sponsor
Shenzhen Geno-Immune Medical I...